(PDF) Metronomic Treatment of Advanced Non-Small-Cell Lung

Metronomic Treatment of Advanced Non-Small-Cell Lung Cancer With Daily Oral Vinorelbine &Ndash; A Phase I Trial

OncoTargets and Therapy - New Zealand

doi 10.2147/ott.s122106

Full Text

Abstract

Available in full text

Categories

Date

February 1, 2017

Authors

Joachim von Pawel

Achim Rittmeyer

Astrid Borgmeier

Rudolf Maria Huber

Publisher

Informa UK Limited

Related search

A Phase I Trial of Temsirolimus and Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer

Infectious Diseases

English

Oral Vinorelbine: A Feasible and Safe Partner for Radiotherapy in the Treatment of Locally Advanced Non-Small Cell Lung Cancer

OncoTargets and Therapy

English

Pemetrexed Versus Vinorelbine Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer in Elderly Patients

Molecular and Clinical Oncology

Cancer Research

English

Gemcitabine Plus Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Phase II Study of Three Different Doses

British Journal of Cancer

Cancer Research

English

P1.01-91 a Phase I Study of Fixed Dose Vinorelbine and Escalating Doses of Ifosfamide in First-Line Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy

English

Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Cancer Research

English

P1.01-47 Phase I/Ii Trial of Dasatinib and Osimertinib in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

Phase I/Ii Trial of Pemetrexed Plus Nab-Paclitaxel in Advanced Solid Tumor Patients With Emphasis on Non-Small Cell Lung Cancer

Investigational New Drugs

English